BERINERT 1500 KIT Canada - Engels - Health Canada

berinert 1500 kit

csl behring canada inc - c1 esterase inhibitor (human) - kit - 1500unit - c1 esterase inhibitor (human) 1500unit - complement inhibitors

LEMTRADA Israël - Engels - Ministry of Health

lemtrada

sanofi israel ltd - alemtuzumab - concentrate for solution for infusion - alemtuzumab 12 mg / 1.2 ml - alemtuzumab - lemtrada is indicated as a single disease modifying therapy in adults with highly active relapsing remitting multiple sclerosis (rrms) for the following patient groups: • patients with highly active disease despite a full and adequate course of treatment with at least one disease modifying therapy (dmt) or • patients with rapidly evolving severe relapsing remitting multiple sclerosis defined by 2 or more disabling relapses in one year, and with 1 or more gadolinium enhancing lesions on brain mri or a significant increase in t2 lesion load as compared to a previous recent mri.

LEMTRADA INFUSION (PARENTERAL) Zuid-Afrika - Engels - South African Health Products Regulatory Authority (SAHPRA)

lemtrada infusion (parenteral)

sanofi-aventis south africa (pty) ltd - infusion (parenteral) - see ingredients - each vial contains alemtuzumab 12,0 mg